Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer

BACKGROUND: Non-small cell lung cancer (NSCLC) often presents at an incurable stage, and majority of patients will be considered for palliative treatment at some point in their disease. Despite recent advances, the prognosis remains poor, with a median overall survival of 12–18 months. Liquid biopsy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapeleris, Joanna, Müller Bark, Juliana, Ranjit, Shanon, Irwin, Darryl, Hartel, Gunter, Warkiani, Majid Ebrahimi, Leo, Paul, O'Leary, Connor, Ladwa, Rahul, O'Byrne, Kenneth, Hughes, Brett G.M., Punyadeera, Chamindie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305346/
https://www.ncbi.nlm.nih.gov/pubmed/35874074
http://dx.doi.org/10.1016/j.heliyon.2022.e09971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305346/
https://www.ncbi.nlm.nih.gov/pubmed/35874074
http://dx.doi.org/10.1016/j.heliyon.2022.e09971

Ejemplares similares